secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2026-06-18T20:05:43+00:00
Accession:  0001808805-26-000027
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology stockholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Elected Parag Mallick and Farzad Nazem as Class II directors with ~97% of votes cast (excluding broker non-votes).
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2026 with 84,937,704 votes for, 27,748 against.
- Advisory say-on-pay approved with 69,994,022 votes for, 268,341 against; broker non-votes 14,708,618.
- Stockholders favored a 1-year frequency for future say-on-pay votes (69,142,818 votes for 1-year).
- Company will hold say-on-pay votes annually until at least the 2032 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880526000027/0001808805-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880526000027/naut-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001808805-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer